Breaking News

BASi Sells Phase I Unit

Bioanalytical Systems, Inc. (BASi) has sold its Baltimore Clinical Pharmacology Research Unit to a subsidiary of Algorithme Pharma Holdings, Inc. for $850,000 in cash, exiting the Phase I market.
   
Algorithme, based in Montreal, is a CRO providing human clinical trials for Phase I and bioequivalence studies, as well as bioanalytical services.  

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters